- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02630667
The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition
The Acute Effects of Fortified Nutritional Supplementation on Cognition, Memory, & Achievement
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Regular breakfast consumption is linked to improved cognitive performance in school-aged children. However, the acute benefits of defined nutrient consumption on brain and cognitive health are not well understood, particularly in preadolescent children. One factor that may relate to brain health and learning in children is the contribution of carbohydrates to the digestion rate of a meal (and associated effects on post-prandial glycemia).
The effects of differentially absorbed carbohydrates on brain and cognition are unknown, especially when ingested via a fortified nutritional beverage providing a balanced array of nutrients. The aim of this study is to investigate the acute, transient effect of nutrient supplementation with varied carbohydrate systems in preadolescent children (i.e., 9-10 years).
Participants will be randomized to receive one of three treatment nutritional formulations containing carbohydrates with varying absorption rates along with a non-caloric placebo. Participants will perform a cognitive battery in the fasted condition, shortly after treatment ingestion, and an hour after ingestion. Group differences in performance will be contrasted to assess the effects of different carbohydrate types on children's cognitive function following an overnight fast.
Findings from this study will inform our understanding of the macronutrient profile of breakfast that may potentially improve children's cognitive performance in the morning.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Illinois
-
Urbana, Illinois, Vereinigte Staaten, 61801
- Department of Kinesiology and Community Health
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Parental/guardian consent.
- Participants must be between the ages of 9-10 years old at the time of testing age
- Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task (below 20/20 vision).
- Participants must have an IQ > 85 (IQ < 85).
Exclusion Criteria:
- Prior diagnosis of cognitive or physical disability, including ADHD (severe asthma, epilepsy, and dependence upon a wheelchair/walking aid, and ADHD Rating Scale score below 85%).
- Use of anti-psychotic, anti-depressant, anti-anxiety medication, as well as those medications used for ADD/ADHD (use of any anti-psychotic, anti-depressant, anti-anxiety, and ADD/ADHD medications).
- Early pubertal status, as measured by a modified test of the Tanner Staging System (onset of puberty as determined by Tanner).
- Lactose intolerance
- Allergies to milk and/or soy
- Adherence to a strict vegan diet
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: SLOW Carbohydrate
Treatment consists of a carbohydrate blend designed to elicit a slow postprandial glycemic response.
|
Treatment consists of a carbohydrate blend designed to elicit a slow postprandial glycemic response
|
Experimental: MEDIUM Carbohydrate
Treatment consists of only one carbohydrate source designed to elicit a medium/moderate postprandial glycemic response.
|
Treatment consists of only one carbohydrate source designed to elicit a medium/moderate postprandial glycemic response
|
Experimental: FAST Carbohydrate
Treatment consists of only one carbohydrate source designed to elicit a fast postprandial glycemic response.
|
Treatment consists of only one carbohydrate source designed to elicit a fast postprandial glycemic response
|
Placebo-Komparator: Non-Caloric Placebo
Non-caloric placebo consisting of artificial sweeteners
|
Treatment consists of a carbohydrate blend designed to elicit a slow postprandial glycemic response
Treatment consists of only one carbohydrate source designed to elicit a medium/moderate postprandial glycemic response
Treatment consists of only one carbohydrate source designed to elicit a fast postprandial glycemic response
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Cognitive Control at 15 minutes Postprandial
Zeitfenster: 15 minutes Postprandial
|
Performance will be assessed using the difference in inverse efficiency (during a modified flanker task) between performance at 15 minutes and baseline/fasted (within 2 hours of wake-time) performance.
|
15 minutes Postprandial
|
Change in Cognitive Control at 70 minutes Postprandial
Zeitfenster: 70 minutes Postprandial
|
Performance will be assessed using the difference in inverse efficiency (during a modified flanker task) between performance at 70 minutes and baseline/fasted (within 2 hours of wake-time).
|
70 minutes Postprandial
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Relational Memory at 30 minutes Postprandial
Zeitfenster: 30 minutes Postprandial
|
Performance will be assessed using the difference in number of swap errors (during a spatial reconstruction task) by calculating the difference between number of errors performed at baseline/fasted (within 2 hours of wake-time) from number of errors at 30 minutes postprandial.
|
30 minutes Postprandial
|
Change in Relational Memory at 85 minutes Postprandial
Zeitfenster: 85 minutes Postprandial
|
Performance will be assessed using the difference in number of swap errors (during a spatial reconstruction task) by calculating the difference between number of errors performed at baseline/fasted (within 2 hours of wake-time) from number of errors at 85 minutes postprandial.
|
85 minutes Postprandial
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Hauptermittler: Charles Hillman, PhD, University of Illinois at Urbana-Champaign
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 12641
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur SLOW Carbohydrate
-
Shanghai Zhongshan HospitalUnbekanntNeubildungen | Lymphom | Entzündung | Krebs | Infektion | Sarkoid | MassenverletzungChina
-
University of PennsylvaniaAktiv, nicht rekrutierend
-
University of PennsylvaniaNoch keine RekrutierungDepression | Depression | Depressive Störung, Major | Depressionen, Unipolar
-
University of Wisconsin, MadisonAbgeschlossenBipolare Störung | Depression | Primäre Schlaflosigkeit | Narkolepsie | Primäre HypersomnieVereinigte Staaten
-
Sheba Medical CenterZurückgezogenWiedereintretende atrioventrikuläre KnotentachykardieIsrael
-
Hacettepe UniversityRekrutierungVerletzungen der Rotatorenmanschette | Risse in der Rotatorenmanschette | Schmerzen, SchulterTruthahn
-
Loma Linda UniversityZurückgezogenMagenneoplasmen | Bauchspeicheldrüsenkrebs
-
Universitas Muhammadiyah YogyakartaNoch keine RekrutierungErmüdung; Hämodialyse; Chronisches Nierenleiden; Lebensqualität
-
Hospital Universitario Insular Gran CanariaRekrutierung
-
Parc de Salut MarAbgeschlossenSupraventrikuläre Tachykardie | Atrioventrikulärer Knoten Re-Entrant-TachykardieSpanien